Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04268771 |
|---|---|
| Brief Title: | A Phase III Transition Study of DRL Rituximab to Reference Medicinal Products (RI-01-007) |
| First Submitted : | January 31, 2020 |
| First Submitted that Met QC Criteria : | February 11, 2020 |
| First Posted : | February 13, 2020 |
| Last Update Submitted that Met QC Criteria : | April 6, 2022 |
| Last Update Posted : | April 7, 2022 |